Cardiovascular Conference at Snowbird

February 5-8, 2020
Cliff Lodge, Snowbird, UT

Currently accepting registrations!
Credit Types: AMA PRA Category 1 (19.0), | Price: $760 - $895 | Early registration saves $100

Program

Wednesday, February 5, 2020
6:45 a.m.
Registration and Continental Breakfast
7:20 a.m.
Welcome and Course Introduction – Course Directors
STRUCTURAL HEART DISEASE
Moderator: Douglas Packer, MD
7:30 a.m.
Valvular Heart Disease Guidelines: The Most Important Changes
Blase Carabello, MD
7:50 a.m.
The Pathophysiology and Management of Functional Mitral Regurgitation
Bernard Gersh, MB, ChB, DPhil
8:10 a.m.
Low Flow Aortic Stenosis: Management Becomes Clearer
Blase Carabello, MD
8:30 a.m.
TAVR Updates for 2020
8:50 a.m.
Tricuspid Valve Regurgitation: Does It Really Matter? What Do You Do About it?
Sabrina Phillips, MD
9:10 a.m.
interventional Procedures for Mitral Valve Disease: Why the Difference in Recent Clinical Trials
9:30 a.m.
Adult Congenital Heart Disease
Sabrina Phillips, MD
9:50 a.m.
Questions and Answers - Drs. Carabello, Gersh, Phillips, and Eleid
10:00 a.m.
Adjourn | Afternoon Session @ 4:00 p.m.
3:45 p.m.
Après-Ski Snacks
RHYTHM DISORDERS AND THEIR MANAGEMENT
Moderator: George Klein, MD
4:00 p.m.
Asymptomatic ECG Abnormalities (Especially AF): When To Ignore and When To Go to the Next Step
George Klein, MD
4:20 p.m.
Management of Clinically Silent Atrial Fibrillation and Cryptogenic Stroke: Double Dilemma
Bernard Gersh, MB, ChB, DPhil
4:40 p.m.
CABANA - One Year Later: Why is CABANA A More Positive Trial?
Douglas Packer, MD
5:00 p.m.
Anticoagulation for Atrial Fibrillation
Christopher Granger, MD
5:20 p.m.
Sleep Apnea and Atrial Fibrillation
Jonathan Piccini, MD
5:40 p.m.
Treatment of Atypical Ventricular Rhythms / Arrhythmogenic Cardiomyopathy (ARVC), Brugada syndrome, LQTC, and More: The Basic and Recent Advances
George Klein, MD
6:00 p.m.
Atrial Fibrillation Management in Athletes
T. Jared Bunch, MD
6:20 p.m.
Emerging Pacing Technologies: Leadless & His Bundle Pacing
Jonathan Piccini, MD
6:40 p.m.
Questions and Answers - Drs. Gersh, Packer, Piccini, and Bunch
6:45 p.m.
Adjourn
Thursday, February 6, 2020
7:00 a.m.
Continental Breakfast
ISCHEMIC HEART DISEASE
Moderator: Bernard Gersh, MB, ChB, DPhil
7:30 a.m.
Antithrombotic Therapy for Patients with Vascular Disease
Christopher Granger, MD
7:50 a.m.
Acute Coronary Syndromes
8:10 a.m.
What Clinicians should know about Spontaneous Coronary Artery Dissection (SCAD) and Other Freaky Syndromes
Rajiv Gulati, MD, PhD
8:30 a.m.
Have ORBITA and FAME 2 Changed Practice?
Christopher Granger, MD
8:50 a.m.
PCI and CABG For Multi-vessel Disease in Stable Angina: Any Evidence for A Preference?
Bernard Gersh, MB, ChB, DPhil
9:10 a.m.
Chronic Total Occlusions – Too Many or Too Few Interventions?
Rajiv Gulati, MD, PhD
9:30 a.m.
Questions and Answers
9:45 a.m.
Adjourn
3:45 p.m.
Après-Ski | Afternoon Session @ 4:00 p.m.
SPECIAL TOPICS
Moderators: Bernard Gersh, MB, ChB, DPhil, Sabrina Phillips, MD
4:00 p.m.
Neurological Complications of Coronary Revascularization
James Klaas, MD
4:20 p.m.
Managing Cryptogenic Stroke: The Role of the Cardiologist
Christopher Granger, MD
4:40 p.m.
Update on Current Treatment for Acute Ischemic Stroke
James Klaas, MD
5:00 p.m.
Left Atrial Appendage Closure – What a Cardiologist Needs to Know
Jonathan Piccini, MD
5:20 p.m.
Chronic Thromboembolic Pulmonary Hypertension: Role of Balloon Angioplasty and Medical Therapy
Robert Frantz, MD
5:40 p.m.
PFO and Atrial Septal Defect: When they need to be closed
Sabrina Phillips, MD
6:00 p.m.
Improving Cognitive Dysfunction Risk in Atrial Fibrillation in 2020
T. Jared Bunch, MD
6:20 p.m.
Illustrative Cases: What to Do With NOACs and DAPT? - Panelists: Drs. Frantz, Klaas, Bunch, Phillips, and Gersh
Christopher Granger, MD
6:45 p.m.
Adjourn
Friday, February 7, 2020
7:00 a.m.
Continental Breakfast
7:30 a.m.
HEART FAILURE MANAGEMENT
Moderator: Christopher O'Connor, MD
7:30 a.m.
Acute Heart Failure: Newest Approaches to Emergency Cases
Christopher O'Connor, MD
7:50 a.m.
Diagnosis and Management of HFpEF
Barry Borlaug, MD
8:10 a.m.
Should New Drugs Be First Line Therapy? Will Biomarkers Tell Us How to Treat?
Christopher O'Connor, MD
8:30 a.m.
When Epidemics Collide: HFpEF and Obesity
Barry Borlaug, MD
8:50 a.m.
Atrial Fibrillation and Heart Failure: Is the Benefit of AF Ablation From CAMERA, AATAC, CASTLE AF and CABANA Real?
Douglas Packer, MD
9:10 a.m.
Identifying the Stage D Patient: When to Refer to Advanced Heart and What to Expect
Robert Frantz, MD
9:30 a.m.
Questions and Answers - Drs. Borlaug, Packer, and Frantz
9:45 a.m.
Adjourn | Afternoon Session @ 4:00 p.m.
3:45 p.m.
Après-Ski Snacks
SPECIAL TOPICS
Moderator: Christopher O'Connor, MD
4:00 p.m.
Reducing Heart Failure Admissions and Length of Stay
Christopher O'Connor, MD
4:20 p.m.
The Forgotten Victims of Diastolic Dysfunction
Barry Borlaug, MD
4:40 p.m.
Palliative Care in Heart Disease
Christopher O'Connor, MD
5:00 p.m.
Hypertrophic Cardiomyopathy: Pathophysiology and Management
Bernard Gersh, MB, ChB, DPhil
5:20 p.m.
Questions and Answers - Drs. Borlaug, Frantz, and Gersh
5:45 p.m.
Illustrative Cases: Heart Failure in Daily Practice - Panelists: Drs. Borlaug, Frantz, Packer, and Gersh
Moderator: Christopher O'Connor, MD
6:30 p.m.
Adjourn & Dinner - Participants, Faculty and Guests are invited. (Primrose Room - Lobby Level)
Saturday, February 8, 2020
6:45 a.m.
Continental Breakfast
PREVENTIVE CARDIOLOGY AND SPECIAL TOPICS
Moderator: Douglas Packer, MD
7:00 a.m.
Socioeconomic Influence on Cardiovascular Disease
Bernard Gersh, MB, ChB, DPhil
7:25 a.m.
Emerging Cardiovascular Risk Factors and Innovative Treatments
Jeffrey Anderson, MD
7:50 a.m.
Treating Diabetes: What the CAD Cardiologist Needs to Know?
Christopher Granger, MD
8:15 a.m.
Using RNA Based Therapies to Treat Lipid Disorders – Has the Future Arrived?
R. Scott Wright, MD
8:40 a.m.
Using Coronary Artery Calcium Screening to Refine CV Risk Stratification and Guide Treatment: Emerging Evidence
Jeffrey Anderson, MD
9:05 a.m.
New and Novel Therapies for LDL Lowering
R. Scott Wright, MD
9:30 a.m.
Pulmonary Hypertension: Revised Diagnostic Criteria, Risk Stratification and Treatment in 2020
Robert Frantz, MD
9:55 a.m.
Genetic Testing of CV Disease
Jeffrey Anderson, MD
10:20 a.m.
Hypertension 2019: Guidelines and Goals
R. Scott Wright, MD
10:45 a.m.
Questions and Answers
11:00 a.m.
Adjourn
Credit Types Offered
  • AMA PRA Category 1™
    19.0

Price: $760 - $895 | Early registration saves $100

Add to Cart

Live Courses

Back to Top